Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05756244 · ClinicalTrials.gov registry record

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

A clinical trial of Pregnancy Related and Venous Thromboembolism, sponsored by University of Calgary.

Recruiting
Registry status
825
Enrollment target
14
Study locations

NCT05756244 is a study of Pregnancy Related and Venous Thromboembolism that is actively recruiting participants, run by University of Calgary. The registered enrollment target is 825 participants, below the 1,955-participant average among 99 other Pregnancy Related trials with a reported enrollment target (58% lower). The trial reports 14 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05756244, a study of Pregnancy Related and Venous Thromboembolism, is actively recruiting participants, sponsored by University of Calgary.

RECRUITING
Registry status
825 participants
Enrollment target
14
Study locations

Study Summary

The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.

Study Locations (14)

Ontario

  • McMaster University Medical Centre - Hamilton
  • The Ottawa Hospital - General Campus - Ottawa
  • Montfort Hospital - Ottawa
  • Mount Sinai Hospital - Toronto

Other

  • Aarhus University Hospital - Aarhus
  • Le Centre Hospitalier Universitaire of Saint-Etienne - Saint-Etienne
  • Hopitaux universitaires de Geneve - Geneva

Alberta

  • Foothills Medical Centre - Calgary
  • Royal Alexandra Hospital - Edmonton

Quebec

  • CHU Sainte-Justine - Montreal
  • The Sir Mortimer B. Davis Jewish General Hospital - Montreal

North Carolina

  • Duke University Hospital - Durham

British Columbia

  • BC Women's Hospital and Health Centre - Vancouver

Manitoba

  • St. Boniface Hospital - Winnipeg

Trial Details

FieldValue
Enrollment Target 825 participants
Start Date 2023-04-04
Est. Completion 2029-12-31

Sponsor

University of Calgary

11 total trials

What the Registry Record Tells You About NCT05756244

The ClinicalTrials.gov registry entry for NCT05756244 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 825 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,955-participant average among 99 other Pregnancy Related trials with a reported enrollment target (58% lower). The listed sponsor is University of Calgary, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.

NCT05756244 reports 14 study locations spanning 7 distinct geographic areas - top geographies include Ontario, Other, Alberta.

Frequently Asked Questions

What is clinical trial NCT05756244 about?

NCT05756244 is a clinical study titled "PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism". The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.

What is the current status of trial NCT05756244?

This trial is currently recruiting. The enrollment target is 825 participants. The study started on 2023-04-04. Estimated completion is 2029-12-31.

What conditions does trial NCT05756244 study?

This clinical trial studies the following conditions: Pregnancy Related, Venous Thromboembolism.

Who is sponsoring clinical trial NCT05756244?

This trial is sponsored by University of Calgary, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05756244 being conducted?

This trial has 14 study locations across North Carolina, Alberta, British Columbia, Manitoba, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.